Advice Pool - Health and Fitness

"Side effects may include: restlessness, irritability, headaches, dry mouth, gastric upset, or impotency." We've all heard this statement before. It, or somet

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

hing similar, follows practically every prescription medication commercial advertisement on television or radio. We all know that there will be side effects t

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

o any medication, because that's the nature of our bodies. We accept these small inconveniences in exchange for the benefits of the drug in question.

We also

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

have a national tendency to trust, with little or no question, what pharmaceutical companies tell us. Why is that? Because we have the Food and Drug Administ

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

ration (FDA) watching out for us. The FDA's job is to screen all new medications for safety and efficacy. They make sure that before a drug goes to market, it

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

has been thoroughly tested. They ensure that the manufacturer is up-front about any adverse side effects.

Recent news articles, though, cast some serious dou

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

bt on our ability to trust the FDA. Take, for example, the headlines regarding the prescription diabetes medication Avandia: "Study: Avandia Raises Risk of He

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

art Attack," "Diabetes Drug Avandia Boosts Heart Attack Risk, Study Finds," and "Lawmakers to Grill GlaxoSmithKline, FDA on Diabetes Drug."

Avandia is a pres

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

cription drug that works by increasing insulin sensitivity, thus allowing diabetics to utilize glucose more efficiently. It has been approved by the FDA for u

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

se in the United States since 1999. Interestingly, Avandia is in a class of drugs of which several were removed from the market due to being suspect as a caus

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

for liver failure. One of these drugs, Rezulin, is responsible for over 500 deaths alone.

Peer-reviewed, published evidence now exists, in the New England J

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

ournal of Medicine, that Avandia may actually increase a patient's risk of heart attack by 43%, and their risk of heart disease by 64%. The FDA reacted to the

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

se findings by simply issuing a warning and recommending that patients using Avandia consult their doctors.

Drug safety expert, Dr. Curt Furberg, requested t

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

hat the FDA remove Avandia from the market. He and Dr. Bruce Psaty both pointed out that Avandia "represents a major failure of the drug-use and drug-approval

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

processes in the United States."

So, how did the FDA miss this? Really, it's somewhat puzzling. Puzzling, considering the fact that New York Attorney Genera

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

Eliot Spitzer has just settled a $2.5 million lawsuit with Glaxo for withholding results of studies on Paxil and its use in children. Puzzling, considering D

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

r. Rosemary Johann-Liang asked for the highest warning put on Avandia following evidence that Avandia caused swelling which could result in heart failure; FDA

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

agents who work closely with Glaxo complained and she was removed from the position. Why wasn't the FDA looking more closely at Glaxo's studies?

We'll see h

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ow this all works out in the months ahead. Capital Hill is now involved. They have investigators probing into the issues. Change is at hand. Lawmakers feel th

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

at the FDA is too accommodating to big pharmaceutical companies like GlaxoSmithKline who, by the way, has sold $3.2 million worth of Avandia yearly since 1999

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/240188/advicepool-Avandia-Heart-Attack-Side-Effects--How-Did-The-FDA-Miss-This.html">Avandia Heart Attack Side Effects - How Did The FDA Miss This?</a>

BB link (for phorums):
[url=http://www.advicepool.org.ua/article/240188/advicepool-Avandia-Heart-Attack-Side-Effects--How-Did-The-FDA-Miss-This.html]Avandia Heart Attack Side Effects - How Did The FDA Miss This?[/url]

This case study explains how report management helps magazine and other industries alike improve their reporting process to be more cost and logistically efficient.

Google has just sent the Search Marketing world into a frenzy of hair pulling and nail biting. Its latest shake up of its algorithm has put paid to unrestrained link swapping. It had gone overboard like Meta tag stuffing before it. Even before this latest revision, all signs indicate that the Search Engines were beginning to devalue reciprocal links and forum signatures in their SERP's. So what is a harried webmaster to do? Are backlinks still relevant to search rankings? If they still count, how do you acquire them without running afoul of the SE's?

Trust is essential to all close relationships. Without trust, relationship fall apart quickly.

Tags

Links

Advice Pool - Avandia Heart Attack Side Effects - How Did The FDA Miss This?

Related Articles: